Literature DB >> 3917883

The effect of airway anaesthesia on the control of breathing and the sensation of breathlessness in man.

A J Winning, R D Hamilton, S A Shea, C Knott, A Guz.   

Abstract

The effect on ventilation of airway anaesthesia, produced by the inhalation of a 5% bupivacaine aerosol (aerodynamic mass median diameter = 4.77 micron), was studied in 12 normal subjects. The dose and distribution of the aerosol were determined from lung scans after the addition to bupivacaine of 99mTc. Bupivacaine labelled in this way was deposited primarily in the central airways. The effectiveness and duration of airway anaesthesia were assessed by the absence of the cough reflex to the inhalation of three breaths of a 5% citric acid aerosol. Airway anaesthesia always lasted more than 20 min. Resting ventilation was measured, by respiratory inductance plethysmography, before and after inhalation of saline and bupivacaine aerosols. The ventilatory response to maximal incremental exercise and, separately, to CO2 inhalation was studied after the inhalation of saline and bupivacaine aerosols. Breathlessness was quantified by using a visual analogue scale (VAS) during a study and by questioning on its completion. At rest, airway anaesthesia had no effect on mean tidal volume (VT), inspiratory time (Ti), expiratory time (Te) or end-tidal PCO2, although the variability of tidal volume was increased. On exercise, slower deeper breathing was produced and breathlessness was reduced. The ventilatory response to CO2 was increased. The results suggest that stretch receptors in the airways modulate the pattern of breathing in normal man when ventilation is stimulated by exercise; their activation may also be involved in the genesis of the associated breathlessness. A hypothesis in terms of a differential airway/alveolar receptor block, is proposed to explain the exaggerated ventilatory response to CO2.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3917883     DOI: 10.1042/cs0680215

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  16 in total

1.  Opposite responses to lidocaine between intrapulmonary mechanical and chemical sensors.

Authors:  Huafeng Li; Lei Du; Peyman Otmishi; Yuwen He; Juan Guardiola; Jerry Yu
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-07-15       Impact factor: 3.619

Review 2.  Palliative medicine.

Authors:  R J George; A L Jennings
Journal:  Postgrad Med J       Date:  1993-06       Impact factor: 2.401

3.  Nebulised drugs in palliative care.

Authors:  S Ahmedzai; C Davis
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

4.  Abraham Guz (1929-2014).

Authors:  Mary Morrell
Journal:  J Physiol       Date:  2014-07-15       Impact factor: 5.182

5.  Cardiorespiratory responses to dynamic exercise after human heart-lung transplantation.

Authors:  M Estenne; G Primo; J C Yernault
Journal:  Thorax       Date:  1987-08       Impact factor: 9.139

6.  Role of airway receptors in the breathing pattern of patients with chronic obstructive lung disease.

Authors:  A J Winning; R D Hamilton; A Guz
Journal:  Thorax       Date:  1985-11       Impact factor: 9.139

Review 7.  Dyspnea.

Authors:  N K Burki
Journal:  Lung       Date:  1987       Impact factor: 2.584

8.  Blockade of airway sensory nerves and dyspnea in humans.

Authors:  Nausherwan K Burki; Lu-Yuan Lee
Journal:  Pulm Pharmacol Ther       Date:  2010-02-25       Impact factor: 3.410

9.  An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea.

Authors:  Mark B Parshall; Richard M Schwartzstein; Lewis Adams; Robert B Banzett; Harold L Manning; Jean Bourbeau; Peter M Calverley; Audrey G Gift; Andrew Harver; Suzanne C Lareau; Donald A Mahler; Paula M Meek; Denis E O'Donnell
Journal:  Am J Respir Crit Care Med       Date:  2012-02-15       Impact factor: 21.405

Review 10.  Possible mechanisms of the anaerobic threshold. A review.

Authors:  M L Walsh; E W Banister
Journal:  Sports Med       Date:  1988-05       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.